Polymeric nanoparticles modified with fatty acids encapsulating betamethasone for anti-inflammatory treatment.
about
Nanoparticle-Enabled Transdermal Drug Delivery Systems for Enhanced Dose Control and Tissue TargetingNanoparticles and direct immunosuppressionEGF Functionalized Polymer-Coated Gold Nanoparticles Promote EGF Photostability and EGFR Internalization for Photothermal TherapyPotential applications and human biosafety of nanomaterials used in nanomedicineAn emerging integration between ionic liquids and nanotechnology: general uses and future prospects in drug delivery.Tacrolimus nanoparticles based on chitosan combined with nicotinamide: enhancing percutaneous delivery and treatment efficacy for atopic dermatitis and reducing dose.Design of Finasteride-Loaded Nanoparticles for Potential Treatment of Alopecia.Functionalized diterpene parvifloron D-loaded hybrid nanoparticles for targeted delivery in melanoma therapy.Lymphoma-targeted treatment using a folic acid-decorated vincristine-loaded drug delivery system.
P2860
Q28079462-AACC6A0E-1916-47D3-8C6C-CDEB2EC30952Q28384480-F1868379-22B8-4ED8-A247-77F345728BE9Q28553040-8F080F09-27D1-42DD-AF6A-AD33E9BEE59EQ32944368-F80A64A1-762C-4BB5-8D02-9F9FCB9E0520Q38681052-3EB7009D-20A7-4975-B882-D36265421D7AQ49165535-E21B08AB-9BB9-4454-9109-6E21FF74990CQ50540368-AFED88B6-2CEB-4ADD-9DB9-5C83D891DF96Q51238627-B58BE23D-CE80-4847-8058-52F3ACDAEEDFQ54942256-D0E7CA54-C50F-421D-88CA-F3647BFFBB64
P2860
Polymeric nanoparticles modified with fatty acids encapsulating betamethasone for anti-inflammatory treatment.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
2015年论文
@zh
2015年论文
@zh-cn
name
Polymeric nanoparticles modifi ...... r anti-inflammatory treatment.
@en
type
label
Polymeric nanoparticles modifi ...... r anti-inflammatory treatment.
@en
prefLabel
Polymeric nanoparticles modifi ...... r anti-inflammatory treatment.
@en
P50
P1476
Polymeric nanoparticles modifi ...... or anti-inflammatory treatment
@en
P2093
Jesús Molpeceres
P304
P356
10.1016/J.IJPHARM.2015.07.044
P407
P50
P577
2015-07-26T00:00:00Z